id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-D-0128-0003,FDA,FDA-2000-D-0128,Medical Devices: Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test Systems; Guidance for Industry and FDA; Availability,Notice,Notice of Availability,2016-12-12T05:00:00Z,2016,12,2016-12-12T05:00:00Z,,2016-12-13T02:01:35Z,,0,0,09000064823fc479
FDA-2000-D-0128-0002,FDA,FDA-2000-D-0128,FDA,Notice,NAD-Notice of Availability of Data,2003-02-06T05:00:00Z,2003,2,,,2008-04-25T01:45:46Z,,0,0,09000064804cf6b1
FDA-2000-D-0128-0001,FDA,FDA-2000-D-0128,FDA,Notice,NAD-Notice of Availability of Data,2000-03-08T05:00:00Z,2000,3,2000-03-08T05:00:00Z,2000-06-08T03:59:59Z,2008-04-25T01:45:46Z,,0,0,09000064804cf677